Families With Pride for Hispanic Sexual Minority Youth
This study, called "Families With Pride" (or "Familias con Orgullo"), is testing a behavioral intervention to help Hispanic sexual minority youth (ages 13-19) who identify as gay, lesbian, or bisexual, or have same-sex attraction/behavior. The goal is to prevent or reduce drug use and depression. We'll be looking to see if the intervention improves parent support and acceptance, family functioning, and reduces stress. To join, youth must be of Hispanic immigrant origin and have told at least one parent about their sexual minority status. The study will measure changes in depression symptoms and drug use frequency and quantity over 30 months. The current recruitment status is unclear, and we plan to enroll 306 participants.
- Study design
- This is an interventional study planning to enroll 306 participants. The phase of the study is not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 30 months to assess changes in depression and drug use.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Families With Pride ("Familias Con Orgullo").
At a glance
Conditions
NCT06057337
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Miami
Coral Gables, Floridastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Guillermo Prado, PhD · PRINCIPAL_INVESTIGATOR · University of Miami
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in depression symptomsBaseline up to 30 months
Change in depression symptoms will be assessed with the Center for Epidemiological Studies Depression Scale. Scores range from 0 to 60 with higher scores indicating the presence of more symptoms.
- Change in frequency of drug useBaseline up to 30 months
Change in drug use will be reported as the number of days of use over the previous 90 days at each timepoint.
- Change in quantity of drug useBaseline up to 30 months
Change in drug use will be reported as the amount of use over the previous 90 days at each timepoint.